Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B

• Status: Completed
• Trial end date: 2004-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety and efficacy of Pegasys + placebo + lamivudine versus lamivudine alone in patients with lamivudine versus lamivudine alone in patients with hepatitis B antigen CHB.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hoffmann-La Roche
• Treatments: Peginterferon alfa-2a

Criteria

Inclusion Criteria:

• Clinical diagnosis of hepatitis B

• Not pregnant

Exclusion Criteria:

• Treatment for hepatitis B in past 6 months

• Other hepatitis infections

• Severe liver disease

• Pregnancy